Institutional filer · SEC 13F · Q4 2025

Seven Fleet Capital Management LP

The reported 13F portfolio of Seven Fleet Capital Management LP (CIK 2092021) - top holdings, how concentrated the book is, and what changed last quarter.

$69.2M
Reported book
85
Positions
#321
of 360 filers

The verdict

Seven Fleet Capital Management LP runs a focused institutional book - $69.2M across 85 reported positions as of Q4 2025, a moderately concentrated portfolio.

$69.2M
reported 13F value
85
disclosed positions
7.6%
in REVOLUTION MEDICINES I
#321
of 360 filers

Reflects long US-equity positions reported to the SEC as of Q4 2025; 13F excludes shorts, cash, non-US and most derivatives, so this is not total AUM.

How to read this page

This page reconstructs an institutional manager's reported equity portfolio from its quarterly SEC Form 13F-HR filings. Any investment manager with at least $100 million in qualifying US-listed equity assets must file a 13F with the Securities and Exchange Commission within 45 days of each quarter-end, disclosing the long positions it held on the last day of that quarter. The "reported book" shown here is the total market value of those disclosed positions, it is not the firm's total assets under management, because 13F covers only long US-listed equities and a defined set of options and convertibles. Short positions, cash, private holdings, sovereign debt, most fixed income, non-US equities, and derivatives are all excluded by rule, so a manager's true economic exposure can differ materially from what appears here. "Positions" counts the distinct securities disclosed; "% of book" shows how much weight each holding carries. Treat these figures as a quarter-lagged snapshot for understanding how a manager is positioned - not as live holdings or investment advice. Each line traces back to a specific filing on SEC EDGAR. This page is provided for informational purposes only and is not financial advice, consult a licensed financial advisor before making investment decisions.

Reported book

$69.2M

13F equity value

Positions

85

Disclosed securities

Top-5 weight

26%

Of reported book

Largest position

7.6%

REVOLUTION MEDICIN

Core + tail

Top-5 position weight

0%100%26%
Top-5 position weight
Share of the book in its 5 largest positions · Q4 2025
Top-5 position weight 26.2%

The five largest positions make up about 26% of Seven Fleet Capital Management LP's reported book as of Q4 2025.

Seven Fleet Capital Management LP's largest reported positions
  1. 1

    7.6% of book

  2. 2

    5.1% of book

  3. 3

    4.5% of book

  4. 4

    4.5% of book

  5. 5

    4.4% of book

  6. 6
    EXELIXIS INC $3.0M

    4.3% of book

Top 6 of 85 positions by value · Q4 2025

Top Reported Holdings

# Security Value % of book
1 REVOLUTION MEDICINES INC $5.2M 7.6%
2 SOLENO THERAPEUTICS INC $3.5M 5.1%
3 LIQUIDIA CORPORATION $3.1M 4.5%
4 CG ONCOLOGY INC $3.1M 4.5%
5 COMPASS THERAPEUTICS INC $3.1M 4.4%
6 EXELIXIS INC $3.0M 4.3%
7 AXSOME THERAPEUTICS INC $2.4M 3.4%
8 TYRA BIOSCIENCES INC $2.1M 3.0%
9 COGENT BIOSCIENCES INC $1.9M 2.8%
10 TANGO THERAPEUTICS INC $1.9M 2.8%
11 XENCOR INC $1.7M 2.4%
12 PHARVARIS N V $1.5M 2.2%
13 TERNS PHARMACEUTICALS INC $1.5M 2.1%
14 BELITE BIO INC $1.5M 2.1%
15 DYNE THERAPEUTICS INC $1.4M 2.0%
16 NUVALENT INC $1.3M 1.8%
17 ASCENDIS PHARMA A/S $1.2M 1.8%
18 AMICUS THERAPEUTICS INC $1.2M 1.7%
19 VAXCYTE INC $1.2M 1.7%
20 AVALO THERAPEUTICS INC $1.2M 1.7%
21 INHIBIKASE THERAPEUTICS INC $1.1M 1.6%
22 MADRIGAL PHARMACEUTICALS INC $1.1M 1.6%
23 GERON CORP $1.0M 1.5%
24 KRYSTAL BIOTECH INC $986K 1.4%
25 ATHIRA PHARMA INC $969K 1.4%

Latest Quarter Trades · Q4 2025

Reading Seven Fleet Capital Management LP's book

A concentrated core with a diversified tail.

  • Open any holding to see who else owns it and how concentrated that stock is. Browse stocks
  • Compare this manager against the largest 13F filers by book size. Top funds by AUM
  • Remember 13F shows long positions only, not total AUM, shorts or non-US holdings. 13F limitations

Informational only, not investment advice. 13F is a 45-day-lagged quarterly snapshot; positions may have changed since the filing date.

Frequently Asked Questions

How big is Seven Fleet Capital Management LP's 13F portfolio?
Seven Fleet Capital Management LP reports $69.2M of long US-equity positions across 85 securities as of Q4 2025. This reflects 13F-disclosed holdings only, it is not the firm's total assets under management.
What is Seven Fleet Capital Management LP's largest position?
Seven Fleet Capital Management LP's largest reported position is REVOLUTION MEDICINES INC at $5.2M, about 7.6% of its reported book as of Q4 2025.
What did Seven Fleet Capital Management LP trade last quarter?
In its Q4 2025 filing, Seven Fleet Capital Management LP opened 85 new positions. Each change is drawn from a line in the firm's 13F-HR filing and can be verified on SEC EDGAR.
Where does Seven Fleet Capital Management LP's holdings data come from?
Every figure renders live from Seven Fleet Capital Management LP's SEC Form 13F-HR filings in EDGAR, a mandatory quarterly disclosure of long US-listed equity positions, filed within 45 days of quarter-end.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q4 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Reported value is not total AUM.